I nflammatory bowel diseases (IBDs) (Crohn's disease [CD] and ulcerative colitis [UC] ) are chronic immunologically mediated disorders traditionally thought of as affecting individuals of European origin or Ashkenazi Jewish heritage. [1] [2] [3] However, it has now emerged as a global disease affecting individuals of every ethnicity and geographic region, with a rapid rise in incidence in regions undergoing urbanization and "westernization". [4] [5] [6] [7] [8] Although the pathogenesis of IBD remains elusive, it is thought to be the result of a dysregulated immune response to gut microbiota in a genetically predisposed host, arising at a confluence of host genetic and external environmental influences. [9] [10] [11] [12] Having an affected family member remains one of the strongest risk factors for development of IBD. [13] [14] [15] [16] [17] Yet, migration from a low-incidence to a high-incidence region results in an increase in risk of IBD in the second generation, [18] [19] [20] and the rapid temporal increase in incidence of IBD globally suggests a pivotal role of the external environment. The emergence of IBD globally offers the possibility of exploring similarities and differences in disease a Authors share co-first authorship;
b Authors share co-senior authorship.
presentation and outcomes across different geographic regions, ethnic groups, and with migration. Multicenter consortia have highlighted both similarities and differences in the genetic architecture of IBD across different ethnic groups and populations. [21] [22] [23] [24] Data also suggest that although some environmental influences may be shared across all populations, there is variation in the magnitude and even the direction of association of certain factors across different ethnic groups. [25] [26] [27] Prior studies examining the impact of ethnicity on disease outcomes were small and biased because of being from referral centers. [28] [29] [30] [31] [32] [33] [34] A robust transethnic analysis of population-based studies of the phenotype and outcome of CD and UC would allow us to infer the implications of shared and dissimilar genes and environmental factors on disease course and shed light on the fundamental pathogenesis of these complex diseases. Consequently, we performed this systematic review and meta-analysis to (1) examine the impact of ethnicity on disease presentation and outcomes of CD and UC, (2) define heterogeneity in outcomes by different geographic regions within each ethnic group, and (3) determine the impact of migration from low-to high-incidence regions on the natural history of IBD within each ethnic group.
Methods

Literature Search
This study was reported according to the Preferred Reporting Items for Systematic Reviews and MetaAnalyses (PRISMA) guidelines. 35 An electronic literature search without language restriction was conducted on Embase and Ovid MEDLINE by using the following combination of keywords: (inflammatory bowel disease* or ulcerative colitis or crohn*) and (ethnic* or nationality or Asian* or Caucasian* or Hispanic* or black or African*) and (population-based or nationwide). Studies published in full until December 2015 were eligible for inclusion. Search of bibliographies was performed to identify additional studies. Initial screening of article titles and abstracts was undertaken by 2 independent teams from the Chinese University of Hong Kong (H.Y.S., L.L.) and Massachusetts General Hospital (A.L., A.N.A.) . Disagreement between the 2 teams was resolved through teleconference. Final decision was made by S.C.N. and A.A. Authors were contacted to obtain additional data if needed.
Selection Criteria
To be included, studies needed to be from populationbased cohorts and present data on phenotype or clinical outcomes among patients with CD, UC, or IBDunspecified (IBDU). Referral center cohorts and those lacking sufficient detail were excluded. Single center studies were included only if they were from large integrated healthcare organizations serving a wide population area whereby care received from the center was not influenced by disease severity, or if the hospital was the only medical center for IBD care in the geographic region, thereby resembling population-based data. Data from studies with multiple reporting periods were pooled if there was no overlap between the different cohorts.
Data Extraction and Covariates
Eligible citations were randomized into 2 groups and reviewed separately by the 2 teams. For each included study, we extracted data on the primary author, year of publication, country and region of origin, ethnicity of the included population, immigration status, study period, study size, population demographics, disease duration, and disease phenotype. 36 The clinical outcomes of interest included cumulative use of mesalamine, corticosteroids, immunomodulators, biologics, and surgery. For immunomodulator or biologic therapy use and surgery, we calculated the rates at 1 and 5 years after diagnosis where available.
Ethnicity was classified as Caucasian, Black, Hispanic, or Asian. Population-based studies from Spain and Latin and South America were assigned Hispanic ethnicity consistent with the definition adopted by the United States Census Bureau. Studies from Asian populations were further divided into those from East Asia (China, Japan, Korea), South Asia (India, Sri Lanka, Malaysia), or the Middle East (Lebanon, Saudi Arabia). Studies from the native non-Arab Israeli population were grouped together with the Caucasians. Participants were considered to be from native populations unless specifically indicated to be immigrants.
Statistical Analysis
Statistical analysis was performed by using Stata 13.2 (StataCorp, College Station, TX) . A DerSimonian and Laird random-effects model was used to calculate the pooled proportion of patients with a positive family history of IBD, disease phenotype, and outcome across each ethnicity. 37, 38 Studies on Asian IBD were stratified by geographic region. We examined the effect of migration on IBD outcomes by comparing disease phenotypes and outcomes between immigrant and native populations of the same ethnicity. We did not formally rate the quality of each study because all included studies were population-based cohorts consisting of unselected patients without selection bias in determination of study population or outcomes. Meta-regression was performed on each of the outcomes to identify influential variables including study size, year of publication, race, and ethnicity. Heterogeneity was assessed by using the Cochrane Q and I 2 statistic, with values >50% and P < .10 indicating significant heterogeneity. A P value <.05 testing heterogeneity between the different groups indicated a statistically significant difference between the groups.
Results
Study Population
A systematic search on MEDLINE and Embase yielded 8285 studies, of which 287 were found to be potentially relevant for scrutiny of the full text (Supplementary Figure 1 ). Among these, 89 studies from referral center cohorts or lacking sufficient information were excluded, and a total of 198 unique studies providing data from 54 countries and 6 continents were included in our final systematic review (Supplementary Tables 1 and 2 ). This included a total of 525,425 patients with IBD, among whom 211,563 had CD, 308,074 had UC, and 5788 had IBDU. Just more than half the cohort (54%) was male. Among 133 studies reporting this information, the mean age of IBD diagnosis was 30 years (range, 4-70 years), with a mean duration of disease of 7 years (range, 1-22 years).
The majority of patients (154, A total of 1653 Asians were immigrants to the West, and the remaining were native residents. A majority of the studies of Hispanics included primarily the white Hispanic population. There was a significant difference in the gender distribution of CD between the ethnic groups. Although 49% and 56% of Caucasian and Hispanic CD patients, respectively, were male, nearly two-thirds of Asian patients (65%) (P < .01 vs Caucasians) and only 43% of Black CD patients were male (P < .01 for difference between the groups) (Supplementary Figure 2) . In contrast, the proportion of males among those with UC did not differ significantly across the 4 ethnic groups (P ¼ .16). Sixty unique studies reported frequency of family history of IBD. The prevalence of a family history of IBD was significantly lower in Asian IBD patients (0.04; 95% confidence interval [CI], 0.03-0.04) compared with White (0.12) or Hispanic (0.13) patients (P < .01) (Supplementary Figure 3) .
Differences in Inflammatory Bowel Disease Phenotype and Natural History by Ethnicity
Among CD patients, a smaller proportion of Blacks had ileal disease (0.14; 95% CI, 0.06-0.22), whereas nearly one-third of Hispanics and one-fourth of Caucasian and Asian CD patients had this phenotype (P ¼ .01) ( Table 1) . A larger proportion of Asian CD patients had isolated upper gastrointestinal involvement (0.08; 95% CI, 0.04-0.11) compared with Caucasians (P < .01). There was a higher proportion of penetrating (0.20; 95% CI, 0. 16-0.25) and lower proportion of non-penetrating, non-stricturing disease in Blacks compared with the other 3 ethnic groups (P < .05). Nearly one-fourth of all Asian CD patients (0.23; 95% CI, 0.17-0.29) and one-third of Black CD patients (0.31; 95% CI, 0.11-0.52) had perianal disease compared with Caucasian CD patients (0.14; 95% CI, 0.12-0.16) (P ¼ .02) (Figure 1 ). Disease extent in UC was similar across all groups, with a higher frequency of proctitis among Caucasians (0.28) and Asians (0.27) compared with Blacks and Hispanics (P < .01).
In CD, mesalamine use was common among all groups (Table 2 ). Asian CD patients had lower rates of surgery compared with the other ethnic groups (P < .01) (Figure 2) . At 1 year, only 9% of Asian patients compared with 18% of Caucasian CD patients underwent surgery (P < .01); this difference persisted at 5 years (17% vs Figure 3 ) (Table 3) (P < .001 for all comparisons). In contrast, the rates of surgery for UC were higher in Blacks and Hispanics. Cumulative use of biologics and immunomodulators was higher in Blacks compared with Caucasians, whereas biologic use was infrequent among Hispanic UC patients.
Caucasian IBD patients were further stratified by whether the studies were from North America or Europe. Although disease location in CD was similar between the 2 regions, penetrating disease (0.21 vs 0.12) and perianal involvement (0.23 vs 0.12) were more common in North American compared with European cohorts (P ¼ .01 for both). In UC, isolated proctitis was less frequent (0.12 vs 0.30) and pancolitis was more common (0.48 vs. 0.34) in North American cohorts. There was no difference in the cumulative rates of surgery or medication use in CD. In UC, cumulative rates of surgery, biologic use, and immunomodulator use were higher in North American cohorts (P < .01 for all).
Differences in Inflammatory Bowel Disease Phenotype and Outcomes Among Asians
A larger proportion of IBD patients from the Middle East reported a family history of IBD (0.13) compared with East (0.03) and South Asians (0.04) with IBD (P < .01) (Supplementary Table 3 ). In East Asians and South Asians with CD, ileocolonic disease (0.52) and colonic involvement (0.44) were the predominant disease location (Supplementary Figure 4) . In UC, isolated proctitis was more common in East Asians, whereas pancolitis was more common in Middle East and South Asians. There were no differences in use of immunosuppressive medications or biologics between the 3 groups; East Asian UC patients used immunomodulators less frequently in comparison with the other groups.
Differences in Inflammatory Bowel Disease Phenotype and Outcomes by Migration Status
Nearly all the studies examining disease characteristics in immigrants focused on Asian IBD patients (Supplementary Table 4 ). Compared with native Asians, a family history of IBD was more common among immigrant IBD patients (0.12 vs 0.03, P ¼ .01) (Supplementary Figure 5) . No significant differences were noted in CD phenotype between the 2 groups. In UC, immigrant patients were less likely to have proctitis and more likely to have left-sided or pancolitis. The rates of medication use and surgery for CD and UC were similar between native and immigrant Asians. Besides race, none of the variables were consistently predictive of each of our outcomes on meta-regression. 
Discussion
Inflammatory bowel disease has emerged as a global disease. 2, 4, 7, 8 Here we demonstrate key similarities as well as distinct differences in the phenotypes and outcomes of IBD across the globe. These findings can help inform us about the phenotypic implications of genetic variants and environmental influences and offer important insights into disease pathogenesis.
We observed a strong male predominance in Asian patients with CD, female preponderance in Blacks, and a balanced representation in Caucasians and Hispanics. A few possible explanations may underlie this phenomenon. The lack of gender specificity in the genetics of IBD suggests that a broad genetic influence does not underpin this demographic phenomenon. 21, 39 A more likely cause is variation in either rate of exposure or susceptibility to specific environmental influences. A ready example is smoking, where the ratio of men:women among current smokers in the United States is 1.3:1, compared with the more skewed 26:1 in China, with a male predominant disease distribution. 40 There is also a need for gender ethnicity interactions influencing susceptibility to environmental effects. A family history of IBD was also more common in Caucasians compared with both Asians and Blacks, suggesting that genetics may contribute a smaller fraction of disease risk in these populations. However, the lower incidence of IBD and consequently the relative rarity in general population may lead to infrequent reports of an affected family member in Asia. As the incidence of IBD, one may observe the proportion with a positive family history increase over time.
Interestingly, there were both similarities and differences in the phenotype of IBD across ethnicities. Prominent differences were a higher frequency of perianal involvement in Asian and Black CD patients and a predominant isolated colonic distribution in South Asians (but not East or Middle East Asians). Surgery for CD or UC was also less common in Asian CD patients, suggesting a milder course of IBD in individuals of this ethnicity. Such variations may be hypothesized to be due to the different distribution of polymorphisms within each ethnic group. The genetic architecture of IBD in Asian and Blacks bears strong resemblance to that in Caucasians. 21, 24, 41 However, some risk alleles are ethnicity specific. Common CD risk alleles in those of European origin such as NOD2, IL-23R, and ATG16L1 are not associated with CD in Asians. 21 In contrast, polymorphisms at tumor necrosis factor superfamily member 15 (TNFSF15), TNFSF8, and HLA-DQA1, DQB1 explain a larger variance in disease risk in Asians. 21 Risk variants at ZNF649 and LSAMP were specific to those of African ancestry. 24 Such differentially distributed single nucleotide polymorphisms may exert an influence on disease phenotype and natural history. For example, TNFSF15 polymorphisms common in the Asian population are associated with strictures, penetrating complications, and perianal fistulas, plausibly explaining the higher incidence of this phenotype within this ethnicity. 42, 43 Phenotype and outcomes may also be explained by variation in the influence of the environment. Little is known about ethnic variability in susceptibility to environmental influences. Smoking, a strong risk factor for CD in Caucasians, has a weaker or no effect in some non-white populations. [44] [45] [46] [47] Extrinsic to disease biology, outcomes may also reflect physician and patient preferences influenced by available treatments and cultural norms.
We observed more similarities than differences between the clinical presentation and outcomes of IBD in immigrant Asian patients compared with native residents. Our findings are consistent with Benchimol et al, 48 who demonstrated that Asian immigrants to Canada had lower rates of surgery for both CD and UC than native Canadians. Together, these findings suggest that perhaps in spite of acculturation and assumption of lifestyle practices of the country of residence, underlying genetics or early life environmental influences before migration may exert a more durable effect on disease phenotype and outcomes, leading to a stronger resemblance to the native country of origin rather than the region of residence.
There are several strengths to our study. This comprehensive systematic review examines the impact of ethnicity on disease presentation and outcomes. Our focus on population-based studies ensured minimization of bias. Our findings highlight the need for further study on the phenotypic implications of both shared and distinct genetic pathways as well as environmental factors across the different ethnic groups.
We readily acknowledge several limitations to the data sources for our study. First, there was a paucity of population-based studies from non-Caucasian populations, limiting the robustness of our estimates. Owing to this, we were also able to perform detailed subgroup analysis only among Asian IBD. Hospital-based studies published since our search yielded findings mostly consistent with our observed associations. [49] [50] [51] Although we grouped together racial and ethnic groups into 4 strata that were broadly inclusive, we acknowledge that there may be more granular differences between the groups that are also influenced by geography, environment, and culture. With increasing mobility around the globe, there is need for further research on the impact of migration on IBD outcomes because such analyses may prove invaluable in determining the relative role of genetics, early childhood, and adult environmental influences on disease course. There was significant statistical heterogeneity between the studies, which was driven in significant part by small individual studies. Indeed, it is this that makes it important for pooled analyses accounting for such heterogeneity to arrive at robust estimates of disease behavior and progression. That most non-Caucasian studies presented data for a single time period also precluded examination of temporal changes across different ethnicities. Further studies are essential to also examine more nuanced outcomes such as secular changes in disease severity, progression, and response to individual therapies. The included studies also comprised a wide time period, which may have impacted rates of disease progression, need and availability of medical therapies, and surgery. Disease phenotype and outcomes were also measured at varying time points at or after diagnosis. Finally, it is possible that some of the differences observed may not be solely due to race or ethnicity but due to other confounders including lifestyle or environmental influences such as smoking or individual disease characteristics. As in most metaanalyses, we did not have such granular individual patient data to adjust for such effects.
In conclusion, in this transethnic analysis of IBD phenotypes and outcomes, we demonstrate significant 
